Significant heterogeneity of published literature comparing radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma

Future Oncol. 2023 Feb;19(4):277-278. doi: 10.2217/fon-2022-0713. Epub 2023 Mar 14.

Authors

Aleena Malik¹, Meghan P Jairam², Ronald Chow^{1

3}, Seyed A Mirshahvalad¹, Patrick Veit-Haibach¹, Charles B Simone 2nd³

Affiliations

¹ Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
² Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
³ New York Proton Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

PMID: 36916468
DOI: 10.2217/fon-2022-0713

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular* / pathology
Catheter Ablation* / adverse effects
Humans
Liver Neoplasms* / pathology
Liver Neoplasms* / radiotherapy
Liver Neoplasms* / surgery
Radiofrequency Ablation*
Radiosurgery* / adverse effects
Treatment Outcome